Shiloh
Editor, Senior Moderator
Source: https://www.cbc.ca/news/politics/vaccines-canada-production-trudeau-1.5897343
Canada inks deal to produce millions of COVID-19 shots domestically
National Research Council-owned facility in Montreal will produce the Novavax vaccine
John Paul Tasker ? CBC News ? Posted: Feb 02, 2021 8:40 AM ET | Last Updated: 35 minutes ago
Prime Minister Justin Trudeau announced today a plan to produce millions of COVID-19 shots at a plant in Montreal starting later this year, securing a domestic supply of vaccines as the global market contends with delivery delays and protectionist measures.
The National Research Council-owned Royalmount facility will churn out tens of millions of doses of the product developed by Maryland-based Novavax, Trudeau said. That company submitted its vaccine to Health Canada for regulatory approval last Friday.
"This is a major step forward to get vaccines made in Canada, for Canadians.... We need as much domestic capacity for vaccine production as possible," Trudeau said. "We won't rest until every Canadian who wants a vaccine has received one."
The agreement will help jump start Canada's largely dormant domestic vaccine manufacturing industry but it will do little to meet the short-term demand for COVID-19 vaccines.
The Novavax product has to be approved by Health Canada regulators, the NRC has to finish building the plant itself and the facility has to be certified to make the vaccines; all of which is expected to take months to complete.
The first Canadian-made Novavax vials won't be produced until the end of the year, the government said, well after the prime minister has promised every Canadian would be inoculated against COVID-19...
Canada inks deal to produce millions of COVID-19 shots domestically
National Research Council-owned facility in Montreal will produce the Novavax vaccine
John Paul Tasker ? CBC News ? Posted: Feb 02, 2021 8:40 AM ET | Last Updated: 35 minutes ago
Prime Minister Justin Trudeau announced today a plan to produce millions of COVID-19 shots at a plant in Montreal starting later this year, securing a domestic supply of vaccines as the global market contends with delivery delays and protectionist measures.
The National Research Council-owned Royalmount facility will churn out tens of millions of doses of the product developed by Maryland-based Novavax, Trudeau said. That company submitted its vaccine to Health Canada for regulatory approval last Friday.
"This is a major step forward to get vaccines made in Canada, for Canadians.... We need as much domestic capacity for vaccine production as possible," Trudeau said. "We won't rest until every Canadian who wants a vaccine has received one."
The agreement will help jump start Canada's largely dormant domestic vaccine manufacturing industry but it will do little to meet the short-term demand for COVID-19 vaccines.
The Novavax product has to be approved by Health Canada regulators, the NRC has to finish building the plant itself and the facility has to be certified to make the vaccines; all of which is expected to take months to complete.
The first Canadian-made Novavax vials won't be produced until the end of the year, the government said, well after the prime minister has promised every Canadian would be inoculated against COVID-19...